HomeXVIVO • STO
add
Xvivo Perfusion AB
Previous close
kr 509.00
Day range
kr 503.00 - kr 510.00
Year range
kr 205.50 - kr 547.00
Market cap
15.94B SEK
Avg Volume
31.55K
P/E ratio
128.21
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 210.35M | 36.08% |
Operating expense | 124.82M | 11.78% |
Net income | 27.19M | 294.90% |
Net profit margin | 12.93 | 190.56% |
Earnings per share | 0.86 | 87.49% |
EBITDA | 43.64M | 340.14% |
Effective tax rate | 16.70% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 480.77M | 180.43% |
Total assets | 2.27B | 27.09% |
Total liabilities | 248.18M | -12.95% |
Total equity | 2.02B | — |
Shares outstanding | 31.50M | — |
Price to book | 7.92 | — |
Return on assets | 3.69% | — |
Return on capital | 4.09% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 27.19M | 294.90% |
Cash from operations | 24.74M | 57.10% |
Cash from investing | -48.44M | -2.15% |
Cash from financing | -3.52M | -22.85% |
Net change in cash | -30.38M | -14.59% |
Free cash flow | -37.94M | 24.91% |
About
Founded
1998
Website
Employees
152
